Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dendritic cell maturation pathway via Peyer's patches activation describes the process by which dendritic cells (DCs) within Peyer's patches in the gut-associated lymphoid tissue undergo functional and phenotypic changes upon encountering antigens. This pathway is critical for initiating adaptive immune responses against pathogens entering through the intestinal mucosa. It involves specialized DC subsets (e.g., CCR6+ DCs), antigen sampling by M cells, upregulation of MHC and costimulatory molecules, and the activation of signaling pathways like NF-κB and ERK/MAPK. Dysregulation of this pathway can lead to impaired immune defense or excessive inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic Cell Maturation Pathway via Peyer's Patches Activation (DC Maturation via Peyer's Patches).